Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect-Reference-Cited by-同舟云学术

Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect

Published:2014-04-21 Issue:12 Volume:57 Page:5057-5071
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Belema Makonen¹,Meanwell Nicholas A.¹

Affiliation:

1. Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm500335h

Reference120 articles.

1. How were new medicines discovered?

2. Impact of high-throughput screening in biomedical research

3. Cell-based assays to identify inhibitors of viral disease

4. Anti-infectives: Can cellular screening deliver?

5. Inhibiting the HIV Integration Process: Past, Present, and the Future

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palladium-Catalyzed/Copper-Mediated Decarbonylative Cross-Coupling of S-Pyrimidyl Thioesters for Biaryl Synthesis;The Journal of Organic Chemistry;2024-06-28

2. Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?;Journal of Medicinal Chemistry;2024-01-05

3. Spirooxindole derivatives as promising antiviral agents: Structure–activity relationship studies and biological perspectives;Spirooxindole;2024

4. CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections;International Journal of Molecular Sciences;2023-12-26

5. Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space;ChemMedChem;2023-11-30